Table 3 The relationship between the expression of LAD1 and clinical pathological features in lung adenocarcinoma.
From: Exploring the expression and prognostic roles of LAD1 in lung adenocarcinoma
Characteristics | LAD1_negative (N = 11) | LAD1_positive (n = 25) | P-value |
|---|---|---|---|
Grade | |||
2 | 8 (72.7%) | 23 (92.0%) | 0.154a |
3 | 3 (27.3%) | 2 ( 8.0%) | |
Location | |||
Left lung | 6 (54.5%) | 10 (40.0%) | 0.483a |
Right lung | 5 (45.5%) | 15 (60.0%) | |
Pleural invasion | |||
0 | 9 (81.8%) | 23 (92.0%) | 0.570a |
1 | 2 (18.2%) | 2 ( 8.0%) | |
pT | |||
1a | 5 (45.5%) | 12 (48.0%) | 0.918a |
1b | 3 (27.3%) | 8 (32.0%) | |
1c | 1 ( 9.1%) | 2 ( 8.0%) | |
2 | 2 (18.2%) | 2 ( 8.0%) | |
4 | 0 ( 0.0%) | 1 ( 4.0%) | |
pN | |||
NA | 0 (0.0 %) | 2 (8.0 %) | 1.000a |
0 | 10 (90.9%) | 20 (80.0%) | |
1 | 1 ( 9.1%) | 3 (12.0%) | |
Gender | |||
Female | 8 (72.7%) | 18 (72.0%) | 1.000a |
Male | 3 (27.3%) | 7 (28.0%) | |
AGE | |||
<60 | 1 ( 9.1%) | 10 (40.0%) | 0.116a |
≥60 | 10 (90.9%) | 15 (60.0%) | |
